MVAC regimen: Difference between revisions
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} Methotrexate-Vinblastine-Adriamycin-Cisplatin Regimen; MVAC Regimen ==Overview== {{PAGENAME}} refers to a regimen consisting o...") |
No edit summary |
||
Line 9: | Line 9: | ||
==Regimen== | ==Regimen== | ||
{{chemo|M|Methotrexate}} | {{chemo|M|Methotrexate}} | ||
{{chemo|V|Vinblastine}} | {{chemo|V|Vinblastine}} | ||
{{chemo|A|Doxorubicin (Adriamycin)}} | {{chemo|A|Doxorubicin (Adriamycin)}} | ||
{{chemo|C|Cisplatin}} | {{chemo|C|Cisplatin}} | ||
==Indications== | ==Indications== | ||
*Advanced-stage [[bladder cancer]].<ref name="pmid24861327">{{cite journal| author=Killock D| title=Bladder cancer: Accelerating MVAC. | journal=Nat Rev Urol | year= 2014 | volume= 11 | issue= 6 | pages= 307 | pmid=24861327 | doi=10.1038/nrurol.2014.128 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24861327 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63486&ns=NCI_Thesaurus }}</ref> | *Advanced-stage [[bladder cancer]].<ref name="pmid24861327">{{cite journal| author=Killock D| title=Bladder cancer: Accelerating MVAC. | journal=Nat Rev Urol | year= 2014 | volume= 11 | issue= 6 | pages= 307 | pmid=24861327 | doi=10.1038/nrurol.2014.128 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24861327 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63486&ns=NCI_Thesaurus }}</ref> | ||
==References== | ==References== |
Latest revision as of 18:20, 27 March 2015
WikiDoc Resources for MVAC regimen |
Articles |
---|
Most recent articles on MVAC regimen Most cited articles on MVAC regimen |
Media |
Powerpoint slides on MVAC regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on MVAC regimen at Clinical Trials.gov Clinical Trials on MVAC regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on MVAC regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on MVAC regimen Discussion groups on MVAC regimen Patient Handouts on MVAC regimen Directions to Hospitals Treating MVAC regimen Risk calculators and risk factors for MVAC regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for MVAC regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Methotrexate-Vinblastine-Adriamycin-Cisplatin Regimen; MVAC Regimen
Overview
MVAC regimen refers to a regimen consisting of methotrexate, vinblastine, doxorubicin (Adriamycin) and cisplatin used for the treatment of advanced-stage bladder cancer.[1][2]
Regimen
MMethotrexate
VVinblastine
ADoxorubicin (Adriamycin)
CCisplatin
Indications
- Advanced-stage bladder cancer.[1][3]
References
- ↑ 1.0 1.1 Killock D (2014). "Bladder cancer: Accelerating MVAC". Nat Rev Urol. 11 (6): 307. doi:10.1038/nrurol.2014.128. PMID 24861327.
- ↑ "NCI Thesaurus".
- ↑ "NCI Thesaurus".